Sara Demy, CEO of Demy-Colton, hosts interactive virtual salons featuring industry leaders and distinguished guests exploring today’s most consequential and disruptive topics in healthcare.

Ophthalmic Drug Delivery: Eye on Innovation
Innovative biotech companies are racing to develop unique drug-delivery systems and agents that overcome the many obstacles that have limited the treatment of serious and increasingly common eye problems. Our panelists will outline the trajectory of this industry’s growth and give an overview of the technologies that are advancing it. Many new ocular drug-transport systems and formulations are being designed as noninvasive, early, and more patient-friendly treatments. Our panelists will also provide insight into bringing these treatments from lab to clinical study and market.

Pixium Vision’s key opinion leader on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD). In case you were unable to attend or would like to hear all or part of it again, the replay of the event is now available online: https://www.pixium-vision.com/KOL-Call-October-2020/

The webinar featured a presentation by José-Alain Sahel, M.D., University of Pittsburgh School of Medicine, Lisa C. Olmos de Koo, M.D., University of Washington and Ralf Hornig, Director of Clinical Affairs, who discussed the current treatment landscape and unmet medical need of Advanced Atrophic dry-AMD. They also shared their experience on how the Prima system is helping their patients regain autonomy and quality of life. Dr Yannick Le Mer and Dr Joseph Martel joined to answer questions following the formal presentation.The Pixium Vision management team also gave an update on the Prima System which has the potential to address this significant unmet medical need in dry-AMD.